Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery.
Employment range in NC
Primary site activity
All company activities
Products under development
Treatment for respiratory syncytial virus (RSV), treatment for COVID-19